Researchers evaluated the outcomes of COVID-19 in patients with rheumatoid arthritis vs the general population, and also explored the outcomes among patients with RA, stratified by sex, race, and medications.
Using real-world data, researchers compared the clinical findings of multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activating syndrome due to systemic juvenile idiopathic arthritis.
GAPNA discusses how making the most of Medicare’s annual wellness visits, preventing falls, and focusing on the 4Ms (what matters, medication, mentation, and mobility) can improve the quality of life of older adults.
In a meta-analysis, researchers investigated the effectiveness of exercise therapy on muscle mass gain in patients with rheumatoid arthritis and identified the factors for treatment efficacy in muscle mass gain.
In a letter to the editor, authors reported the case of chilblain lupus-like cutaneous reaction that fulfilled the criteria for systemic lupus erythematosus in a patient who received treatment with immune checkpoint inhibitors for oropharyngeal cancer.
